The parallels between the bird flu 'vaccine' push and the COVID-19 'vaccine' campaign reveal a coordinated effort to capitalize on health crises for profit and control In a concerning development that echoes the recent COVID-19 "Vaccine" saga, pharmaceutical giant Moderna has secured a whopping $176 million from the U.S. government to fast-track the development of a new mRNA flu vaccine.
This scenario, as reported by The Telegraph, has fueled the urgency behind the government's investment in Moderna's new gene therapy injection, marketed as a 'vaccine'.
In the first quarter of this year, the company reported a staggering billion-dollar loss, as the demand for coronavirus "Vaccines" has nearly vanished.
A New Goldmine for Vaccine Makers? Moderna isn't the only player in this game.
Pfizer, another major beneficiary of the COVID-19 "Vaccine" boom, is similarly on the lookout for new lucrative opportunities.
Last month, the European Union signed a contract for the delivery of over 40 million bird flu vaccines to 15 countries, with the first shipment headed to Finland.
Setting the Tone: A Warning for the Public The parallels between the current push for an avian flu gene therapy marketed as a 'vaccine' and the recent COVID-19 vaccine campaign are striking.
https://rairfoundation.com/next-big-scam-modernas-new-mrna-bird-flu/
No comments:
Post a Comment